Klinické štúdie CHOPN v štáte Oklahoma
8 štúdií pre CHOPN hľadá účastníkov v zariadeniach v štáte Oklahoma.
Mestá v štáte Oklahoma
Oficiálny text štúdie (anglicky)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Norman
- Research Site, Oklahoma City
- Research Site, Tulsa
Prebieha náborFáza 3
Vek 40 až 80 · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Layrek Clinical Research- Site Number : 8400066, Tulsa
Prebieha náborFáza 3
Vek 40 až 80 · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT07190222Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Epic Medical Research - Chickasha- Site Number : 8400097, Chickasha
Prebieha náborFáza 3
Vek 40 až 80 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07190209A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Oklahoma City
- Research Site, Tulsa
Prebieha náborFáza 2
Vek 40 a viac · Všetky pohlavia · Aktualizované 9. 9. 2026 · NCT07082738A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Oklahoma City
- Research Site, Tulsa
Prebieha náborFáza 3
Vek 40 až 80 · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Oklahoma City
Prebieha náborFáza 3
Vek 40 až 80 · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT06883305eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Edmond
Prebieha náborFáza 3
Vek 40 až 75 · Všetky pohlavia · Aktualizované 28. 7. 2026 · NCT07177339Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Hightower Clinical, Oklahoma City
Prebieha náborObservačná štúdia
Vek 50 a viac · Všetky pohlavia · Aktualizované 5. 8. 2025 · NCT06122077Z ClinicalTrials.gov, dáta načítané 4. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.